Page 14 - Pharmaceutical
Lupin to market Eli Lilly's insulin analog product in India
The Mumbai-based pharma company will market and sell Eglucent, a new brand of Lilly's insulin analog Lispro, while Eli Lilly will be responsible for manufacturing and import
 "Lupin to market Eli Lilly's insulin analog product in India")
Lupin receives US FDA nod for sleep disorder drug armodafinil
The approved product is a generic version of Cephalon Inc's Nuvigil tablet, which recorded annual US sales of $ 515.6 million
 "Lupin receives US FDA nod for sleep disorder drug armodafinil")
Patheon acquires Roche's APIs manufacturing site in US
It will provide Patheon with a major APIs operation in the US capable of supporting products from clinical scale to commercial manufacturing
 "Patheon acquires Roche's APIs manufacturing site in US")
Sun Pharma launches first branded ophthalmic product BromSite in US
Developed by its California-based subsidiary, InSite Vision, the product is also the first bromfenac ophthalmic solution formulated in DuraSite, a polymer-based drug delivery system
 "Sun Pharma launches first branded ophthalmic product BromSite in US")
Pfizer to launch new products under Corex brand
At the same time, the company will discontinue the production of the current Corex cough syrup formulation (a combination of codeine phosphate and chlorpheniramine maleate)
 "Pfizer to launch new products under Corex brand")
Johnson & Johnson in talks to acquire Actelion
Switzerland-based Actelion, a biopharmaceutical company that focuses on drugs for rare diseases, reported revenue of Swiss Francs (CHF) 2.05 billion in 2015
 "Johnson & Johnson in talks to acquire Actelion")
Sun Pharma acquires Russia's Biosintez for $ 24 million
Acquisition will enhance local manufacturing capability of Sun Pharma, which also assume a debt of approximately $ 36 million as part of this transaction, in Russia
 "Sun Pharma acquires Russia's Biosintez for $ 24 million")
Make plant inspection reports public, Indian Pharmaceutical Alliance tells government
Recommendation comes in the backdrop of inspections at 76 manufacturing units carried out by CDSCO and state drug regulators
 "Make plant inspection reports public, Indian Pharmaceutical Alliance tells government")
Bliss GVS Pharma bags $ 111 million contract in Kenya
The company operates an innovative public-private engagement model to address unmet healthcare requirements in Kenya through its chain of clinics and partner service providers
 "Bliss GVS Pharma bags $ 111 million contract in Kenya")
Clariant aims to start Cuddalore healthcare packaging facility in 2017
The company also plans to expand production by adding high-capacity multi-lane production line for its versatile Continu-Strip desiccant packets
 "Clariant aims to start Cuddalore healthcare packaging facility in 2017")
Sanofi India to collaborate with NIPER Kolkata for pharma education and R&D
Two sides will be collaborate in the areas of pharmaceuticals and consumer healthcare products to cater to the current and future needs of the industry
 "Sanofi India to collaborate with NIPER Kolkata for pharma education and R&D")
Roche launches global initiative for cancer treatment research
The company will invest up to Swiss Francs 100 million (about $ 100 million) to support basic and clinical research collaborations within the imCORE Network
 "Roche launches global initiative for cancer treatment research")
Biocon and Mylan submit application for biosimilar cancer drug trastuzumab in US
The application, which is believed to be the first for a proposed biosimilar trastuzumab in the US, marks first US regulatory submission through the Mylan-Biocon collaboration
 "Biocon and Mylan submit application for biosimilar cancer drug trastuzumab in US")
Biocompatibles pleads guilty to misbranding, agrees to pay $ 36 mn
The medical device maker, who has pleaded guilty to misbranding its embolic device LC Bead, will pay the amount to resolve criminal liability and False Claims Act allegations
 "Biocompatibles pleads guilty to misbranding, agrees to pay $ 36 mn")
Merck invests Euro 250 mn to expand pharma business' production in China
The investment will support Merck's expansion in China, which is expected to become the world's second-largest pharmaceutical market by 2018
 "Merck invests Euro 250 mn to expand pharma business' production in China")
European Medicines Agency accepts Mylan-Biocon's insulin glargine application
Glargine is one of the three insulin analogs being co-developed for the global marketplace by Mylan and Biocon - who are partners for a broad portfolio of biosimilars and insulin analogs
 "European Medicines Agency accepts Mylan-Biocon's insulin glargine application")
Sun Pharma buys US-based Ocular Technologies for $ 40 million
The acquisition of Ocular Technologies, which is developing Seciera for the treatment of Dry Eye Disease, will enhance Sun Pharma's specialty ophthalmic pipeline
 "Sun Pharma buys US-based Ocular Technologies for $ 40 million")
Glenmark receives US FDA's nod for antifungal cream
The company has received final approval for nystatin and triamcinolone acetonide cream (100,000 units per gm and 1 mg per gm)
IIIM-CSIR opens cGMP plant in Jammu for phyto-pharmaceuticals
The CGMP facility will help in extraction, formulation and packaging of medicinal plant based phyto-pharmaceutical drugs
 "IIIM-CSIR opens cGMP plant in Jammu for phyto-pharmaceuticals")
Large scale imports of APIs from China worries Indian pharma industry
Overwhelming dependence on China for crucial active pharmaceutical ingredients (APIs) and intermediates has emerged as a main worrying area, as per the Assocham-RNCOS study
 "Large scale imports of APIs from China worries Indian pharma industry")
